JUPW Share Price Rises More Than 15% Before Market: Why It Happened
- Jupiter Wellness, Inc. (NASDAQ: JUPW) stock price has risen more than 15% before market. That’s why it happened.
Jupiter Wellness, Inc. (NASDAQ: JUPW) stock price has risen more than 15% before market. Investors are responding positively to the company’s announcement of a licensing agreement for 2 patents covering the use of aspartame for the treatment of contact dermatitis.
The agreement signed with the Oklahoma Medical Research Foundation covers a license for 2 patents issued in the United States, 7,288,527 and US 7,816,327 – which cover the use of aspartame for the treatment of contact dermatitis . And under the terms of the agreement, Jupiter Wellness has the exclusive worldwide license to use the patent rights, know-how and materials related to NL-Alpha-Aspartyl-L-Phenylalanine-1-Methyl ester to manufacture, use, distribute, sublicense and sell Licensed Products or Licensed Services.
Jupiter Wellness had separately filed an additional patent for the use of a CBD / aspartame combination for the treatment of various skin conditions, including atopic dermatitis (eczema), published under number US 20210038513.
Jupiter Wellness previously reported that in a double-blind, placebo-controlled clinical trial, JW-100 (a new topical formulation containing CBD and aspartame) significantly reduced the ISGA score in 50% of patients with of atopic dermatitis after only two weeks of use. . And the company is currently preparing for a pre-IND meeting with the FDA.
“The timely licensing of these patents protects us from the use of aspartame in commercial products that treat a range of skin conditions. We will continue to expand our global patent strategy to protect our consumer and Rx products. “
– Dr Glynn Wilson, President and Scientific Director of Jupiter Wellness
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.